##  [Global eCTD 4.0 Electronic Submissions Simplified!](/medicinal-products/global-ectd-4.0-electronic-submissions-simplified) 

# Global eCTD 4.0 Electronic Submissions Simplified!

##### Stay Ahead of the Curve with Freyr - The First to Launch eCTD 4.0 submission services and regulatory software for PMDA &amp; US FDA

Freyr is one of the first regulatory service providers fully equipped for eCTD 4.0 electronic publishing and submissions. With proven delivery for Japan PMDA and pilot readiness for US FDA, we offer unmatched expertise, proprietary tools, and full-spectrum support for a seamless global transition.

eCTD 4.0 US FDA and eCTD 4.0 Japan PDMA are currently accepting eCTD 4.0 submissions voluntarily; however, Japan will mandate eCTD 4.0 from April 2026. Other countries are still in the process of implementation.



#### Be eCTD 4.0 Submission-Ready Before the Deadline!









## Why Top Pharma Companies Trust Freyr for eCTD 4.0

![]()

##### Early Mover Advantage

- First in the industry to deliver **LIVE eCTD 4.0 submissions for PMDA**
- Ready for US FDA eCTD 4.0 pilots (Q3 2025) and EU readiness by end of 2025



![]()

##### Deep Regulatory Collaboration

- Partnering with **PMDA, US FDA &amp; EMA** on sample and pilot submissions
- Hosting the **Japan-wide eCTD 4.0 Industry Summit** (August 2025)



![]()

##### Proven Performance

- **200,000+ global eCTD submissions** delivered
- **99% “Right First Time**” record
- **Zero Refusal-to-Receiv**e (RTR) outcomes





<a class="fr-animateBtn mpr-ad-drug-labeling" id="mpr-adc-auto-popup-title">Take the first step toward seamless global compliance </a>







## What We Offer

![Key Features and Benefits]()  


**eCTD 4.0 Advisory &amp; Training**

- Country-specific guidance for Japan, US, EU &amp; more
- In-house team trainings, SOPs, and region-specific templates





![Key Features and Benefits]()  


**Full-Service Submission Support**

- End-to-end eCTD 4.0 lifecycle management: IND, NDA, ANDA, MAA, BLA, LCM, etc.
- Publishing, validation, dispatch &amp; agency follow-up





![Key Features and Benefits]()  


**freya. Submit: Robust Software Tool for Global eCTD submissions**

- Use Freyr’s industry-proven eCTD publishing and electronic submission software, freya. Submit.
- Automation solutions to reduce manual QC efforts





![Key Features and Benefits]()  


**Dedicated COEs for PMDA &amp; FDA**

- 25+ Japan-focused regulatory experts
- Seamless coordination across global hubs: US, Japan, EU, India







<a class="fr-animateBtn mpr-ad-drug-labeling" id="mpr-adc-auto-popup-title">Book your free consultation</a>







## Global eCTD 4.0 Implementation and Submissions

- ![]() Freyr is partnering with major pharmaceutical companies in Japan to support eCTD 4.0 submissions to the PMDA, including training, live submissions, and proof-of-concept (POC) activities-successfully delivering multiple submissions to date.
- ![]()As a leading software partner, Freyr is working closely with the PMDA to provide technical consultation, ensuring full compliance with eCTD 4.0 Japan-specific requirements.
- ![]()Freyr is also supporting multiple clients with pilot submission for the eCTD 4.0 US FDA and is currently collaborating with EU Health Authorities on samples of eCTD 4.0 submission.
- ![]() Through strategic partnerships and regulatory expertise, Freyr is helping global pharmaceutical companies smoothly transition to eCTD 4.0-starting with Japan and expanding into the US and EU markets.



#### Global eCTD 4.0 transition across:

![Canada]()

Health Canada



![Australia]()

Australia TGA



![Brazil]()

Brazil ANVISA



![South Korea]()

South Korea MFDS







#### eCTD 4.0 benefits:

- **Efficiency**: eCTD 4.0 streamlines the regulatory submission process, saving sponsors time and money.
- **Accuracy**: Controlled vocabularies in eCTD 4.0 ensure that regulatory submissions are consistent and accurate.
- **Communication**: eCTD 4.0 improves communication between sponsors and regulatory authorities by providing a more collaborative review process.







<a class="fr-animateBtn mpr-ad-drug-labeling" id="mpr-adc-auto-popup-title">Book your free consultation</a>





## Don't Wait for Mandates. Lead the Change.

Most health authorities will mandate eCTD 4.0 by 2026–2027. Be ready before it’s too late.   
With 20+ global hubs, 400+ publishing experts, and partnerships with 200+ pharma companies, Freyr is the preferred regulatory partner for leading life sciences brands worldwide.



#### ![Canada]() Schedule a   
30-minute Consultation



#### ![Canada]() Request a   
Free Readiness Audit



#### ![Canada]() Get Live   
Demo of Freya.Submit™





<a class="fr-animateBtn mpr-ad-drug-labeling" id="mpr-adc-auto-popup-title">Contact our eCTD 4.0 experts today</a>